| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | EFCAB5 MATN1 FSTL4 FAT1 NRXN1 TCHHL1 NOTCH4 UNC13B HSPG2 NID2 FAT4 PCDHGA6 MAN1C1 PCDHB2 BCAN MMRN1 SNED1 EYS CDH22 P4HTM CELSR2 NCAN PCDHGC3 CDH6 | 1.65e-06 | 749 | 213 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 1.57e-05 | 15 | 213 | 4 | GO:0140776 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 2.34e-05 | 6 | 213 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 2.34e-05 | 6 | 213 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | cadherin binding | SEPTIN9 TRPC4 OBSCN PTPRB HSPA1A HSPA8 COBLL1 EPN2 EEF1G CDH22 CCNB2 PRDX1 CDH6 | 7.57e-05 | 339 | 213 | 13 | GO:0045296 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RIN3 TRIO OBSCN MCF2 HPS1 HERC2 ARHGEF19 ARHGEF5 DENND1A MADD | 1.96e-04 | 231 | 213 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.11e-04 | 28 | 213 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SEPTIN9 TRPC4 OBSCN PTPRB NRXN1 HSPA1A HSPA8 DSCAM COBLL1 EPN2 EEF1G CDH22 CCNB2 PRDX1 KIRREL1 CDH6 TNXB | 2.49e-04 | 599 | 213 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | denatured protein binding | 3.37e-04 | 3 | 213 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.99e-04 | 14 | 213 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | flippase activity | 7.29e-04 | 17 | 213 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | MAGEA4 MDM2 BRCA1 HERC2 HSPA1A HSPA1B HSPA8 PML APBB1 RNF34 SORBS1 | 1.03e-03 | 337 | 213 | 11 | GO:0031625 |
| GeneOntologyMolecularFunction | death receptor agonist activity | 1.11e-03 | 5 | 213 | 2 | GO:0038177 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 DTNBP1 ADD2 PTPN13 PTPRA NRXN1 AJM1 HSPA8 UNC13B WHRN DSCAM PPFIA4 PPFIA1 APBB1 PCDHB2 BCAN SORBS1 REST SLC6A1 CDH22 NCAN CNTNAP2 ST8SIA2 PALM KIRREL1 PATJ PCDHGC3 CDH6 | 8.70e-07 | 974 | 212 | 28 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 DTNBP1 ADD2 PTPN13 NRXN1 HSPA8 UNC13B DSCAM PPFIA4 PPFIA1 APBB1 PCDHB2 BCAN SORBS1 REST SLC6A1 NCAN CNTNAP2 ST8SIA2 PALM PCDHGC3 CDH6 | 2.46e-06 | 685 | 212 | 22 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 TRIO MAP6 MATN1 FSTL4 MCF2 RREB1 DTNBP1 BRWD3 FAT1 NRXN1 HPS1 SCFD1 NOTCH4 WHRN HSPG2 DSCAM APBB1 BCAN REST ATP10A CDH22 CELSR2 ZNF335 CNTNAP2 ST8SIA2 PALM GOLGA8B RIMS1 CDH6 | 5.31e-06 | 1194 | 212 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT1 NECTIN4 FAT4 DSCAM PCDHGA6 PCDHB2 CDH22 CELSR2 PCDHGC3 CDH6 | 2.47e-05 | 187 | 212 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | RIN3 FSTL4 MCF2 DTNBP1 MDM2 TRIP13 ADD2 PTPN13 BRCA1 NRXN1 EHMT2 SCFD1 HSPA1A HSPA1B HSPA8 DYNC1I2 PML HSPG2 SCAF8 PPFIA1 ADCK1 KANK3 CGNL1 | 3.01e-05 | 864 | 212 | 23 | GO:0051129 |
| GeneOntologyBiologicalProcess | response to cocaine | 9.02e-05 | 71 | 212 | 6 | GO:0042220 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MCAM FAT1 NRXN1 NECTIN4 FAT4 DSCAM PCDHGA6 PCDHB2 CDH22 CELSR2 PCDHGC3 CDH6 | 1.02e-04 | 313 | 212 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle priming | 1.05e-04 | 2 | 212 | 2 | GO:0010808 | |
| GeneOntologyBiologicalProcess | acrosomal vesicle exocytosis | 1.22e-04 | 10 | 212 | 3 | GO:0060478 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | SEPTIN9 RABGAP1 BRCA1 NRXN1 EHMT2 SYNE2 SCFD1 HSPA1A HSPA1B SDC1 ARHGEF5 | 1.60e-04 | 280 | 212 | 11 | GO:1902115 |
| GeneOntologyBiologicalProcess | peptidyl-lysine trimethylation | 1.66e-04 | 11 | 212 | 3 | GO:0018023 | |
| GeneOntologyCellularComponent | anchoring junction | IL16 TRPC4 OBSCN MCAM FAT1 PTPRA NRXN1 AJM1 SYNE2 NECTIN4 HSPA1A HSPA1B HSPA8 USP53 HSPG2 ARHGEF5 PPFIA1 SORBS1 PANX2 CDH22 LMO7 CNTNAP2 KIRREL1 CGNL1 PATJ PCDHGC3 CDH6 | 2.45e-06 | 976 | 213 | 27 | GO:0070161 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.46e-05 | 141 | 213 | 9 | GO:0048786 | |
| GeneOntologyCellularComponent | cell-cell junction | TRPC4 OBSCN FAT1 NRXN1 AJM1 NECTIN4 USP53 SORBS1 PANX2 CDH22 LMO7 CNTNAP2 KIRREL1 CGNL1 PATJ PCDHGC3 CDH6 | 1.25e-04 | 591 | 213 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 3.49e-04 | 14 | 213 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | nuclear body | MAGEA4 SP3 IL16 OBSCN RREB1 MDM2 EFTUD2 BRCA1 EHMT2 CDT1 HSPA1A HSPA1B PML USP36 ZCCHC8 AHCTF1 APBB1 RNF34 RFWD3 PAPOLG WDFY3 | 3.83e-04 | 903 | 213 | 21 | GO:0016604 |
| Domain | EGF | MATN1 FAT1 NRXN1 NOTCH4 HSPG2 NID2 BCAN MMRN1 SNED1 EYS CELSR2 NCAN CNTNAP2 TNXB | 1.62e-10 | 126 | 211 | 14 | PF00008 |
| Domain | EGF | MATN1 FAT1 NRXN1 NOTCH4 HSPG2 NID2 FAT4 BCAN MMRN1 SNED1 EYS CELSR2 NCAN CNTNAP2 TNXB | 7.60e-08 | 235 | 211 | 15 | SM00181 |
| Domain | EGF_3 | MATN1 FAT1 NRXN1 NOTCH4 HSPG2 NID2 FAT4 BCAN MMRN1 SNED1 EYS CELSR2 NCAN CNTNAP2 TNXB | 7.60e-08 | 235 | 211 | 15 | PS50026 |
| Domain | EGF_CA | MATN1 FAT1 NOTCH4 HSPG2 NID2 FAT4 MMRN1 SNED1 EYS CELSR2 NCAN | 1.38e-07 | 122 | 211 | 11 | SM00179 |
| Domain | EGF-like_dom | MATN1 FAT1 NRXN1 NOTCH4 HSPG2 NID2 FAT4 BCAN MMRN1 SNED1 EYS CELSR2 NCAN CNTNAP2 TNXB | 1.62e-07 | 249 | 211 | 15 | IPR000742 |
| Domain | EGF-like_Ca-bd_dom | MATN1 FAT1 NOTCH4 HSPG2 NID2 FAT4 MMRN1 SNED1 EYS CELSR2 NCAN | 1.63e-07 | 124 | 211 | 11 | IPR001881 |
| Domain | LAM_G_DOMAIN | 1.99e-07 | 38 | 211 | 7 | PS50025 | |
| Domain | Laminin_G_2 | 2.89e-07 | 40 | 211 | 7 | PF02210 | |
| Domain | EGF-like_CS | MATN1 FAT1 NRXN1 NOTCH4 HSPG2 NID2 FAT4 BCAN MMRN1 SNED1 EYS CELSR2 NCAN CNTNAP2 TNXB | 2.97e-07 | 261 | 211 | 15 | IPR013032 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.39e-07 | 106 | 211 | 10 | IPR000152 | |
| Domain | EGF_2 | MATN1 FAT1 NRXN1 NOTCH4 HSPG2 NID2 FAT4 BCAN MMRN1 SNED1 EYS CELSR2 NCAN CNTNAP2 TNXB | 3.61e-07 | 265 | 211 | 15 | PS01186 |
| Domain | LamG | 5.71e-07 | 44 | 211 | 7 | SM00282 | |
| Domain | EGF_1 | MATN1 FAT1 NRXN1 NOTCH4 HSPG2 FAT4 BCAN MMRN1 SNED1 EYS CELSR2 NCAN CNTNAP2 TNXB | 1.29e-06 | 255 | 211 | 14 | PS00022 |
| Domain | ASX_HYDROXYL | 1.98e-06 | 100 | 211 | 9 | PS00010 | |
| Domain | Laminin_G | 3.92e-06 | 58 | 211 | 7 | IPR001791 | |
| Domain | - | 1.22e-05 | 95 | 211 | 8 | 2.60.120.200 | |
| Domain | hEGF | 1.40e-05 | 28 | 211 | 5 | PF12661 | |
| Domain | Ig_V-set | OBSCN MCAM BTN1A1 NECTIN4 IGSF3 HSPG2 DSCAM VSTM2A BCAN NCAN KIRREL1 | 1.69e-05 | 199 | 211 | 11 | IPR013106 |
| Domain | - | TRIO OBSCN FSTL4 MCAM PTPRB BTN1A1 NECTIN4 IGSF3 SECTM1 HSPG2 COL6A3 DSCAM VSTM2A BCAN PKHD1L1 SNED1 LRIG1 NCAN KIRREL1 TNXB MYBPC2 | 2.13e-05 | 663 | 211 | 21 | 2.60.40.10 |
| Domain | Cadherin_CS | 3.32e-05 | 109 | 211 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 4.31e-05 | 113 | 211 | 8 | PS00232 | |
| Domain | Cadherin | 4.31e-05 | 113 | 211 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 4.59e-05 | 114 | 211 | 8 | PS50268 | |
| Domain | - | 4.59e-05 | 114 | 211 | 8 | 2.60.40.60 | |
| Domain | CA | 4.88e-05 | 115 | 211 | 8 | SM00112 | |
| Domain | Cadherin-like | 5.19e-05 | 116 | 211 | 8 | IPR015919 | |
| Domain | Ig-like_fold | TRIO OBSCN FSTL4 MCAM PTPRB BTN1A1 NECTIN4 IGSF3 SECTM1 HSPG2 COL6A3 DSCAM VSTM2A BCAN PKHD1L1 SNED1 LRIG1 NCAN KIRREL1 TNXB MYBPC2 | 5.30e-05 | 706 | 211 | 21 | IPR013783 |
| Domain | Cadherin | 5.87e-05 | 118 | 211 | 8 | IPR002126 | |
| Domain | IGc2 | TRIO OBSCN FSTL4 MCAM NECTIN4 IGSF3 HSPG2 DSCAM LRIG1 KIRREL1 MYBPC2 | 7.75e-05 | 235 | 211 | 11 | SM00408 |
| Domain | Ig_sub2 | TRIO OBSCN FSTL4 MCAM NECTIN4 IGSF3 HSPG2 DSCAM LRIG1 KIRREL1 MYBPC2 | 7.75e-05 | 235 | 211 | 11 | IPR003598 |
| Domain | IG | TRIO OBSCN FSTL4 MCAM BTN1A1 NECTIN4 IGSF3 HSPG2 DSCAM VSTM2A BCAN LRIG1 NCAN KIRREL1 MYBPC2 | 9.29e-05 | 421 | 211 | 15 | SM00409 |
| Domain | Ig_sub | TRIO OBSCN FSTL4 MCAM BTN1A1 NECTIN4 IGSF3 HSPG2 DSCAM VSTM2A BCAN LRIG1 NCAN KIRREL1 MYBPC2 | 9.29e-05 | 421 | 211 | 15 | IPR003599 |
| Domain | EGF_Ca-bd_CS | 1.16e-04 | 97 | 211 | 7 | IPR018097 | |
| Domain | ARHGEF5_35 | 1.27e-04 | 2 | 211 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 1.27e-04 | 2 | 211 | 2 | IPR029212 | |
| Domain | EGF_CA | 1.31e-04 | 99 | 211 | 7 | PS01187 | |
| Domain | ConA-like_dom | 2.00e-04 | 219 | 211 | 10 | IPR013320 | |
| Domain | IGv | 2.04e-04 | 75 | 211 | 6 | SM00406 | |
| Domain | V-set | 2.51e-04 | 184 | 211 | 9 | PF07686 | |
| Domain | PH_dom-like | TRIO OBSCN MCF2 PLEKHS1 RABGAP1 PLEKHM1 PTPN13 RABGAP1L OSBP2 ARHGEF19 ARHGEF5 APBB1 GRB10 WDFY3 | 3.63e-04 | 426 | 211 | 14 | IPR011993 |
| Domain | CYTOCHROME_B5_2 | 3.74e-04 | 13 | 211 | 3 | PS50255 | |
| Domain | CYTOCHROME_B5_1 | 3.74e-04 | 13 | 211 | 3 | PS00191 | |
| Domain | Growth_fac_rcpt_ | 4.04e-04 | 156 | 211 | 8 | IPR009030 | |
| Domain | P_typ_ATPase_c | 4.72e-04 | 14 | 211 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 4.72e-04 | 14 | 211 | 3 | IPR032631 | |
| Domain | Cyt-b5 | 4.72e-04 | 14 | 211 | 3 | PF00173 | |
| Domain | P-type_ATPase_IV | 4.72e-04 | 14 | 211 | 3 | IPR006539 | |
| Domain | - | 4.72e-04 | 14 | 211 | 3 | 3.10.120.10 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 4.72e-04 | 14 | 211 | 3 | IPR001199 | |
| Domain | Neurexin-like | 4.72e-04 | 14 | 211 | 3 | IPR003585 | |
| Domain | 4.1m | 4.72e-04 | 14 | 211 | 3 | SM00294 | |
| Domain | Cyt-b5 | 4.72e-04 | 14 | 211 | 3 | SM01117 | |
| Domain | PhoLip_ATPase_C | 4.72e-04 | 14 | 211 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 4.72e-04 | 14 | 211 | 3 | PF16209 | |
| Domain | IG_LIKE | TRIO OBSCN FSTL4 MCAM BTN1A1 NECTIN4 IGSF3 HSPG2 DSCAM VSTM2A BCAN LRIG1 NCAN KIRREL1 MYBPC2 | 4.84e-04 | 491 | 211 | 15 | PS50835 |
| Domain | - | TRIO OBSCN MCF2 PLEKHS1 RABGAP1 PLEKHM1 PTPN13 RABGAP1L OSBP2 ARHGEF19 ARHGEF5 APBB1 GRB10 | 5.26e-04 | 391 | 211 | 13 | 2.30.29.30 |
| Domain | Ig-like_dom | TRIO OBSCN FSTL4 MCAM BTN1A1 NECTIN4 IGSF3 HSPG2 DSCAM VSTM2A BCAN LRIG1 NCAN KIRREL1 MYBPC2 | 6.21e-04 | 503 | 211 | 15 | IPR007110 |
| Domain | HSP70 | 7.14e-04 | 16 | 211 | 3 | PF00012 | |
| Domain | DH_1 | 7.25e-04 | 63 | 211 | 5 | PS00741 | |
| Domain | FAM86 | 7.51e-04 | 4 | 211 | 2 | IPR029426 | |
| Domain | FAM86 | 7.51e-04 | 4 | 211 | 2 | PF14904 | |
| Domain | HSP70_2 | 8.60e-04 | 17 | 211 | 3 | PS00329 | |
| Domain | HSP70_1 | 8.60e-04 | 17 | 211 | 3 | PS00297 | |
| Domain | HSP70_3 | 8.60e-04 | 17 | 211 | 3 | PS01036 | |
| Domain | Znf_FYVE | 8.65e-04 | 38 | 211 | 4 | IPR000306 | |
| Domain | GDS_CDC24_CS | 9.55e-04 | 39 | 211 | 4 | IPR001331 | |
| Domain | Hsp_70_fam | 1.02e-03 | 18 | 211 | 3 | IPR013126 | |
| Domain | RhoGEF | 1.03e-03 | 68 | 211 | 5 | SM00325 | |
| Domain | ZF_FYVE | 1.05e-03 | 40 | 211 | 4 | PS50178 | |
| Domain | C2-set_2 | 1.16e-03 | 41 | 211 | 4 | PF08205 | |
| Domain | CD80_C2-set | 1.16e-03 | 41 | 211 | 4 | IPR013162 | |
| Domain | RhoGEF | 1.17e-03 | 70 | 211 | 5 | PF00621 | |
| Domain | DH_2 | 1.17e-03 | 70 | 211 | 5 | PS50010 | |
| Domain | NIDO_dom | 1.24e-03 | 5 | 211 | 2 | IPR003886 | |
| Domain | NIDO | 1.24e-03 | 5 | 211 | 2 | SM00539 | |
| Domain | NIDO | 1.24e-03 | 5 | 211 | 2 | PF06119 | |
| Domain | NIDO | 1.24e-03 | 5 | 211 | 2 | PS51220 | |
| Domain | - | 1.25e-03 | 71 | 211 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.25e-03 | 71 | 211 | 5 | IPR000219 | |
| Domain | Ig_I-set | 1.46e-03 | 190 | 211 | 8 | IPR013098 | |
| Domain | I-set | 1.46e-03 | 190 | 211 | 8 | PF07679 | |
| Domain | Kinesin-like | 1.85e-03 | 6 | 211 | 2 | IPR022164 | |
| Domain | DUF3694 | 1.85e-03 | 6 | 211 | 2 | PF12473 | |
| Domain | Liprin | 1.85e-03 | 6 | 211 | 2 | IPR029515 | |
| Domain | Quino_amine_DH_bsu | 1.87e-03 | 22 | 211 | 3 | IPR011044 | |
| Domain | Syndecan | 2.57e-03 | 7 | 211 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 2.57e-03 | 7 | 211 | 2 | IPR027789 | |
| Domain | AAA | 2.81e-03 | 52 | 211 | 4 | PF00004 | |
| Domain | EGF_CA | 2.91e-03 | 86 | 211 | 5 | PF07645 | |
| Domain | ATPase_AAA_core | 3.22e-03 | 54 | 211 | 4 | IPR003959 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 1.78e-05 | 51 | 153 | 6 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 1.78e-05 | 51 | 153 | 6 | MM14499 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.84e-05 | 17 | 153 | 4 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.84e-05 | 17 | 153 | 4 | MM14907 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.63e-05 | 18 | 153 | 4 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.63e-05 | 18 | 153 | 4 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.63e-05 | 18 | 153 | 4 | MM14703 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.63e-05 | 18 | 153 | 4 | M27043 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 4.15e-05 | 59 | 153 | 6 | M11215 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 5.65e-05 | 20 | 153 | 4 | M27258 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.01e-04 | 23 | 153 | 4 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.01e-04 | 23 | 153 | 4 | M12627 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.20e-04 | 24 | 153 | 4 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.20e-04 | 24 | 153 | 4 | M630 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 1.66e-04 | 26 | 153 | 4 | M708 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.73e-04 | 76 | 153 | 6 | M19832 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.73e-04 | 76 | 153 | 6 | M27219 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 2.30e-04 | 80 | 153 | 6 | M800 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.43e-04 | 52 | 153 | 5 | MM14949 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 2.43e-04 | 52 | 153 | 5 | MM14743 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 2.46e-04 | 81 | 153 | 6 | M39490 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 2.75e-04 | 154 | 153 | 8 | M27697 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.13e-04 | 157 | 153 | 8 | MM15226 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 3.31e-04 | 13 | 153 | 3 | MM14952 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.56e-04 | 160 | 153 | 8 | M27498 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.75e-04 | 57 | 153 | 5 | M27251 | |
| Pathway | PID_ATM_PATHWAY | 4.80e-04 | 34 | 153 | 4 | M84 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 6.50e-04 | 97 | 153 | 6 | M9400 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 9.06e-04 | 142 | 153 | 7 | MM15576 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 9.06e-04 | 142 | 153 | 7 | MM15431 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 9.68e-04 | 70 | 153 | 5 | MM14824 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 9.89e-04 | 41 | 153 | 4 | M27257 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 1.07e-03 | 19 | 153 | 3 | MM15523 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 1.07e-03 | 19 | 153 | 3 | M927 | |
| Pathway | WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1 | 1.15e-03 | 5 | 153 | 2 | M39330 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.20e-03 | 149 | 153 | 7 | M41805 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.49e-03 | 77 | 153 | 5 | MM15044 | |
| Pathway | PID_RHOA_REG_PATHWAY | 1.53e-03 | 46 | 153 | 4 | M68 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.62e-03 | 300 | 153 | 10 | M610 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 1.66e-03 | 47 | 153 | 4 | MM15296 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.66e-03 | 47 | 153 | 4 | MM14925 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 1.66e-03 | 22 | 153 | 3 | MM15519 | |
| Pubmed | MCAM ARFIP1 EFTUD2 FAT1 PTPN13 BRCA1 EHMT2 PDS5A SCFD1 IGSF3 USP36 FAT4 DSCAM PPFIA1 CNTRL APBB1 PCDHB2 IPO4 PKHD1L1 ARCN1 EEF1G PHACTR4 KIRREL1 CGNL1 | 1.50e-10 | 777 | 217 | 24 | 35844135 | |
| Pubmed | TRIO OBSCN FSTL4 MCAM PTPRA NECTIN4 IGSF3 SECTM1 DSCAM VSTM2A LRIG1 KIRREL1 | 5.07e-10 | 162 | 217 | 12 | 25826454 | |
| Pubmed | TANC2 TRIO MAP6 SEPTIN9 RABGAP1 RPS6KC1 NRXN1 AJM1 CDC16 RABGAP1L FADS2 HSPA1B HSPA8 IGSF3 ADCK1 APBB1 GRIA4 SORBS1 PANX2 ARCN1 MADD SLC6A1 EEF1G CELSR2 PRDX1 CNTNAP2 PALM RIMS1 | 7.27e-10 | 1139 | 217 | 28 | 36417873 | |
| Pubmed | TANC2 IL16 TRIO MAP6 SEPTIN9 ADD2 PTPRA AJM1 HSPA1A HSPA1B HSPA8 MICAL1 NPEPPS PPFIA4 PPFIA1 BCAN SORBS1 ARCN1 MADD EPN2 SLC6A1 EEF1G LRIG1 LMO7 CRACDL NCAN PRDX1 PALM PPP1R18 RIMS1 CGNL1 | 1.72e-09 | 1431 | 217 | 31 | 37142655 | |
| Pubmed | TANC2 TRIO MAP6 NHSL2 TRPC4 ARMCX4 EFTUD2 NRXN1 EHMT2 SYNE2 DNAJC9 HERC2 HSPA8 DSCAM NPEPPS PPFIA1 GRIA4 SORBS1 IPO4 CELSR2 NCAN PRDX1 GOLGA8B RIMS1 WDFY3 | 2.15e-09 | 963 | 217 | 25 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 TRIO PTPN13 RABGAP1L SYNE2 NR3C2 PML USP53 ZCCHC8 ARHGEF5 PPFIA1 COBLL1 APBB1 GRB10 SORBS1 DENND1A MADD EPN2 C2CD3 LMO7 PHACTR4 CGNL1 PATJ | 5.81e-09 | 861 | 217 | 23 | 36931259 |
| Pubmed | 7.34e-09 | 5 | 217 | 4 | 17182002 | ||
| Pubmed | TRIO OBSCN DTNBP1 MDM2 EHMT2 NFE2L1 SYNE2 ZBTB40 MYO18B USP1 HSPA1B HSPA8 HSPG2 COL6A3 SORBS1 EEF1G MYBPC2 | 1.86e-08 | 497 | 217 | 17 | 23414517 | |
| Pubmed | 5.26e-08 | 55 | 217 | 7 | 14656967 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SEPTIN9 RREB1 EFTUD2 FBXO38 ZBTB40 CDT1 SCFD1 HSPA8 DYNC1I2 ZCCHC8 SCAF8 REST PAPOLG SETD2 LMO7 CHTF18 ZNF335 PHACTR4 PPP1R18 RIMS1 | 1.03e-07 | 774 | 217 | 20 | 15302935 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ZFYVE16 SEPTIN9 ARFIP1 NECTIN4 HSPA1A HSPA8 COBLL1 SORBS1 EPN2 EEF1G LMO7 CCNB2 PHACTR4 PRDX1 PPP1R18 GOLGA8B PATJ | 1.17e-07 | 565 | 217 | 17 | 25468996 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MCAM ADD2 FAT1 PTPRA ATP11A SDC1 IGSF3 USP53 PPFIA1 APBB1 EPN2 CELSR2 CRACDL PHACTR4 PALM KIRREL1 PATJ | 1.29e-07 | 569 | 217 | 17 | 30639242 |
| Pubmed | TANC2 IL16 EARS2 RREB1 MDM2 TRIP13 BRWD3 FAT1 BRCA1 EHMT2 CDC16 TAF7L PML USP36 NID2 KAT5 ZCCHC8 PPFIA1 AHCTF1 BTBD18 DHRS7B SETD2 ZZZ3 WDFY3 | 1.57e-07 | 1116 | 217 | 24 | 31753913 | |
| Pubmed | PML3 Orchestrates the Nuclear Dynamics and Function of TIP60. | 2.40e-07 | 3 | 217 | 3 | 19150978 | |
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 23352621 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 2.40e-07 | 3 | 217 | 3 | 15129916 | |
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 28025138 | ||
| Pubmed | SP3 GTPBP6 URB2 PTPN13 BRCA1 EHMT2 CDC16 DNAJC9 PDS5A BOP1 HERC2 SDC1 USP36 KAT5 ZCCHC8 SCAF8 PPFIA1 AHCTF1 IPO4 DENND1A EPN2 SETD2 EEF1G GTF2F1 CRACDL RCL1 PPP1R18 PATJ | 2.40e-07 | 1497 | 217 | 28 | 31527615 | |
| Pubmed | EFCAB5 ZGRF1 EFTUD2 FBXO38 PPFIA1 COBLL1 TEX15 EEF1G ZNF335 CGNL1 UTP14C | 2.92e-07 | 234 | 217 | 11 | 36243803 | |
| Pubmed | EFCAB5 GTPBP6 NHSL2 TRIP13 RPS6KC1 BRCA1 NRXN1 TCHHL1 SYNE2 ATP11A USP1 HSPA8 DYNC1I2 PCDHGA6 PPFIA4 PPFIA1 CNTRL GRIA4 DHRS7B C2CD3 LMO7 PRDX1 PALM RIMS1 PCDHGC3 UTP14C MYBPC2 | 3.94e-07 | 1442 | 217 | 27 | 35575683 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MAGEB2 ZGRF1 MCAM NCKAP5 MDM2 EFTUD2 HSPG2 COL6A3 BTBD18 LRIG1 ZNF335 FIGNL1 CDH6 | 5.48e-07 | 363 | 217 | 13 | 14691545 |
| Pubmed | FAM86B1 GTPBP6 TRIO NCKAP5 ARMCX4 BRWD3 PTPN13 PTPRA EHMT2 HERC2 HSPA1A HSPA1B UNC13B DSCAM ZCCHC8 APBB1 SORBS1 RIPK4 ARCN1 MADD SLC6A1 THAP4 P4HTM LMO7 WDFY3 | 5.49e-07 | 1285 | 217 | 25 | 35914814 | |
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 9.54e-07 | 4 | 217 | 3 | 18299791 | |
| Pubmed | 9.54e-07 | 4 | 217 | 3 | 18379898 | ||
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 9.54e-07 | 4 | 217 | 3 | 22956628 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 ZGRF1 RABGAP1 MDM2 PML ZCCHC8 SORBS1 IPO4 PAPOLG SETD2 GTF2F1 ZZZ3 LMO7 CCNB2 CGNL1 PATJ | 1.05e-06 | 588 | 217 | 16 | 38580884 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 RIN3 GTPBP6 TRIO OBSCN PLEKHM1 FAT1 HERC2 IGSF3 UNC13B HSPG2 ARHGEF19 AKNA GRB10 DENND1A MADD C2CD3 CELSR2 ZNF335 KANK3 PALM WDFY3 | 1.89e-06 | 1105 | 217 | 22 | 35748872 |
| Pubmed | TRIO RREB1 ARFIP1 PTPN13 HSPA1B HSPA8 DYNC1I2 ARHGEF5 PPFIA4 TEX15 CHTF18 | 1.95e-06 | 284 | 217 | 11 | 29459677 | |
| Pubmed | TRIO MAP6 SEPTIN9 RABGAP1 HSPA1A HSPA1B SDC1 COBLL1 DENND1A GOLGA8B | 2.06e-06 | 230 | 217 | 10 | 35449600 | |
| Pubmed | EARS2 ARFIP1 ADD2 EFTUD2 PTPN13 EHMT2 SYNE2 DNAJC9 FADS2 BOP1 SCFD1 HERC2 HSPA1A HSPA1B HSPA8 PML PPFIA1 AHCTF1 APBB1 NVL IPO4 ABCB10 PHACTR4 RCL1 PALM KIRREL1 | 2.32e-06 | 1487 | 217 | 26 | 33957083 | |
| Pubmed | 2.37e-06 | 5 | 217 | 3 | 33849647 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 2.37e-06 | 5 | 217 | 3 | 33139401 | |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 2.37e-06 | 5 | 217 | 3 | 11584023 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 2.37e-06 | 5 | 217 | 3 | 16906134 | |
| Pubmed | TRIO ZFYVE16 MCAM DTNBP1 ADD2 FBXO38 PTPN13 PTPRA PTPRB SYNE2 HERC2 USP1 USP36 PPFIA1 MADD GTF2F1 C2CD3 CCNB2 PALM PPP1R18 KIRREL1 | 3.02e-06 | 1049 | 217 | 21 | 27880917 | |
| Pubmed | SEPTIN9 PTPRB EHMT2 HSPA1B HSPA8 DYNC1I2 PML APBB1 MMRN1 EEF1G LMO7 PPP1R18 | 3.16e-06 | 360 | 217 | 12 | 33111431 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 3.31e-06 | 142 | 217 | 8 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 3.49e-06 | 143 | 217 | 8 | 20198315 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SEPTIN9 MDM2 ARFIP1 FAT1 PTPRA RABGAP1L FADS2 PDS5A SCFD1 HSPA1A HSPA8 NOVA1 NPEPPS EPN2 SETD2 CELSR2 ABCB10 LMO7 PALM WDFY3 PCDHGC3 | 3.60e-06 | 1061 | 217 | 21 | 33845483 |
| Pubmed | SEPTIN9 EHMT2 CDC16 BOP1 HSPA1A HSPA1B ZCCHC8 MAN1C1 AHCTF1 COBLL1 GRB10 IPO4 GTF2F1 LMO7 | 3.88e-06 | 503 | 217 | 14 | 16964243 | |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 4.73e-06 | 6 | 217 | 3 | 15963462 | |
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 4.73e-06 | 6 | 217 | 3 | 25281747 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 4.73e-06 | 6 | 217 | 3 | 7988674 | |
| Pubmed | 4.73e-06 | 6 | 217 | 3 | 9305631 | ||
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 4.73e-06 | 6 | 217 | 3 | 11032181 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 GTPBP6 IL17REL TRIO SEPTIN9 OBSCN RABGAP1 TRIP13 BRWD3 PLEKHM1 EXD3 PTPN13 PTPRB ATP11A USP53 SCAF8 MAN1C1 NPEPPS GRB10 ATP10A DENND1A DHRS7B THAP4 RIMS1 PATJ | 7.42e-06 | 1489 | 217 | 25 | 28611215 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RREB1 FBXO38 BRCA1 EHMT2 ZNF483 DNAJC9 ZBTB40 PDS5A BOP1 HERC2 ARHGEF5 AHCTF1 NVL PAPOLG RCL1 | 7.45e-06 | 608 | 217 | 15 | 36089195 |
| Pubmed | RIN3 NCKAP5 DTNBP1 BRCA1 EHMT2 MYO18B PPFIA4 GRB10 PANX2 CELSR2 RIMS1 | 7.94e-06 | 329 | 217 | 11 | 17474147 | |
| Pubmed | 8.23e-06 | 7 | 217 | 3 | 9551980 | ||
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 8.23e-06 | 7 | 217 | 3 | 10205060 | |
| Pubmed | 9.02e-06 | 77 | 217 | 6 | 19505873 | ||
| Pubmed | Recombination in the class III region of the mouse major histocompatibility complex. | 9.87e-06 | 22 | 217 | 4 | 7916002 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 1.31e-05 | 8 | 217 | 3 | 9122205 | |
| Pubmed | TRIO MCAM ARFIP1 ADD2 PTPN13 SCFD1 PPFIA1 EPN2 CELSR2 PHACTR4 PALM KIRREL1 | 1.52e-05 | 421 | 217 | 12 | 36976175 | |
| Pubmed | 1.67e-05 | 128 | 217 | 7 | 30995482 | ||
| Pubmed | MAGEB2 TRIO ZFYVE16 RREB1 CDT1 USP1 SCAF8 PPFIA1 NVL MADD PAPOLG SETD2 GTF2F1 ZNF792 KIRREL1 PATJ | 1.68e-05 | 733 | 217 | 16 | 34672954 | |
| Pubmed | 1.68e-05 | 51 | 217 | 5 | 11853319 | ||
| Pubmed | ZFYVE16 MCAM RABGAP1 ARFIP1 PLEKHM1 RPS6KC1 PTPN13 SYNE2 FADS2 SCFD1 APBB1 MADD LRIG1 | 1.93e-05 | 504 | 217 | 13 | 34432599 | |
| Pubmed | 1.94e-05 | 131 | 217 | 7 | 35356984 | ||
| Pubmed | 1.96e-05 | 9 | 217 | 3 | 21763498 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PHF20 RREB1 EFTUD2 BRCA1 EHMT2 CDC16 DNAJC9 PDS5A HSPA1B HSPA8 USP36 KAT5 ZCCHC8 AHCTF1 REST CREM RFWD3 THAP4 SETD2 ZZZ3 LMO7 CCNB2 | 2.24e-05 | 1294 | 217 | 22 | 30804502 |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 2.78e-05 | 10 | 217 | 3 | 11932435 | |
| Pubmed | 2.78e-05 | 10 | 217 | 3 | 12832005 | ||
| Pubmed | 2.78e-05 | 10 | 217 | 3 | 7906708 | ||
| Pubmed | 2.78e-05 | 10 | 217 | 3 | 23921388 | ||
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 3.56e-05 | 30 | 217 | 4 | 16186258 | |
| Pubmed | 3.59e-05 | 98 | 217 | 6 | 19554387 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 3.81e-05 | 11 | 217 | 3 | 27708256 | |
| Pubmed | 3.81e-05 | 11 | 217 | 3 | 24318877 | ||
| Pubmed | 3.81e-05 | 11 | 217 | 3 | 7832766 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 3.88e-05 | 2 | 217 | 2 | 12411538 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 3786141 | ||
| Pubmed | Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. | 3.88e-05 | 2 | 217 | 2 | 21827697 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 7813466 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 3.88e-05 | 2 | 217 | 2 | 26923070 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 26976620 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 3.88e-05 | 2 | 217 | 2 | 20876613 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 20223214 | ||
| Pubmed | Munc13-1 is required for presynaptic long-term potentiation. | 3.88e-05 | 2 | 217 | 2 | 21849565 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 3.88e-05 | 2 | 217 | 2 | 23704948 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 3.88e-05 | 2 | 217 | 2 | 12207910 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 29572464 | ||
| Pubmed | Association study between the TNXB locus and schizophrenia in a Japanese population. | 3.88e-05 | 2 | 217 | 2 | 17192952 | |
| Pubmed | RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone. | 3.88e-05 | 2 | 217 | 2 | 11797009 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 12714332 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 19299581 | ||
| Pubmed | Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions. | 3.88e-05 | 2 | 217 | 2 | 12114509 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 16971451 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 29631603 | ||
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 3.88e-05 | 2 | 217 | 2 | 26197988 | |
| Pubmed | Regulation of the Dbl proto-oncogene by heat shock cognate protein 70 (Hsc70). | 3.88e-05 | 2 | 217 | 2 | 15802271 | |
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 19157555 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 18625847 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 37298493 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 18841484 | ||
| Pubmed | 3.88e-05 | 2 | 217 | 2 | 15498567 | ||
| Pubmed | Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells. | 3.88e-05 | 2 | 217 | 2 | 17482577 | |
| Interaction | YWHAH interactions | TANC2 RIN3 TRIO NHSL2 EFTUD2 PTPN13 RABGAP1L SYNE2 NR3C2 HSPA1A USP53 ZCCHC8 ARHGEF5 PPFIA1 COBLL1 CNTRL APBB1 GRB10 SORBS1 RIPK4 DENND1A MADD EPN2 USP21 C2CD3 LMO7 PHACTR4 RIMS1 CGNL1 PATJ | 1.87e-06 | 1102 | 213 | 30 | int:YWHAH |
| Interaction | PICK1 interactions | MAGEA4 IL16 NHSL2 ARFIP1 NECTIN4 PDS5A ATP11A OSBP2 SDC1 IGSF3 KAT5 ARHGEF5 PPFIA1 GRB10 GRIA4 FAM90A1 ZZZ3 KIRREL1 | 4.99e-06 | 490 | 213 | 18 | int:PICK1 |
| Interaction | PTPRF interactions | TRIO SEPTIN9 MCAM PTPN13 PTPRA HSPA1A HSPA8 PML PPFIA1 EEF1G NCAN MRAP2 | 7.39e-06 | 233 | 213 | 12 | int:PTPRF |
| Interaction | PTPRG interactions | 1.28e-05 | 102 | 213 | 8 | int:PTPRG | |
| Interaction | NXPH2 interactions | 2.35e-05 | 33 | 213 | 5 | int:NXPH2 | |
| Interaction | YWHAZ interactions | TANC2 BDP1 RIN3 MAP6 MDM2 EFTUD2 PTPN13 PTPRA BRCA1 NRXN1 SYNE2 HERC2 HSPA1A HSPA1B HSPA8 PML ARHGEF5 PPFIA1 COBLL1 GRB10 SORBS1 RIPK4 DENND1A MADD EPN2 USP21 EEF1G LMO7 PHACTR4 WDFY3 CGNL1 | 2.37e-05 | 1319 | 213 | 31 | int:YWHAZ |
| Interaction | CAV1 interactions | TRIO ZFYVE16 SEPTIN9 TRPC4 MCAM ADD2 RPS6KC1 PTPN13 NR3C2 SCFD1 HSPA1A IGSF3 PML NPEPPS PPFIA1 COBLL1 APBB1 ARCN1 PHACTR4 PALM KIRREL1 | 2.95e-05 | 724 | 213 | 21 | int:CAV1 |
| Interaction | SNAP25 interactions | 3.26e-05 | 116 | 213 | 8 | int:SNAP25 | |
| Interaction | PTPRS interactions | 3.72e-05 | 153 | 213 | 9 | int:PTPRS | |
| Interaction | ARL14 interactions | 3.92e-05 | 119 | 213 | 8 | int:ARL14 | |
| Interaction | SIRT6 interactions | MDM2 RPS6KC1 EFTUD2 FAT1 EHMT2 CDC16 DNAJC9 PDS5A BOP1 HERC2 HSPA8 PML FAT4 NVL SETD2 EEF1G CELSR2 CHTF18 PCDHGC3 | 4.09e-05 | 628 | 213 | 19 | int:SIRT6 |
| Interaction | RRM2 interactions | 4.97e-05 | 123 | 213 | 8 | int:RRM2 | |
| Interaction | TRIM26 interactions | 5.30e-05 | 199 | 213 | 10 | int:TRIM26 | |
| Interaction | XAGE1A interactions | 6.92e-05 | 41 | 213 | 5 | int:XAGE1A | |
| Interaction | HMGN1 interactions | 7.70e-05 | 168 | 213 | 9 | int:HMGN1 | |
| Interaction | PACSIN3 interactions | 7.76e-05 | 131 | 213 | 8 | int:PACSIN3 | |
| Interaction | RYK interactions | PTPRA HSPA1B SECTM1 FAT4 PCDHGA6 NPEPPS PCDHB2 CELSR2 KIRREL1 PCDHGC3 | 9.00e-05 | 212 | 213 | 10 | int:RYK |
| Interaction | C2CD4B interactions | 9.77e-05 | 44 | 213 | 5 | int:C2CD4B | |
| Interaction | ABL1 interactions | MDM2 BRCA1 HSPA8 MICAL1 APBB1 GRB10 SORBS1 EEF1G GTF2F1 PHACTR4 PRDX1 | 1.03e-04 | 259 | 213 | 11 | int:ABL1 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.06e-05 | 66 | 154 | 6 | 722 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.21e-05 | 161 | 154 | 8 | 593 | |
| GeneFamily | ATPase phospholipid transporting | 2.56e-04 | 15 | 154 | 3 | 1210 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.64e-04 | 40 | 154 | 4 | 592 | |
| GeneFamily | Heat shock 70kDa proteins | 3.78e-04 | 17 | 154 | 3 | 583 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.28e-04 | 4 | 154 | 2 | 574 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 4.99e-04 | 163 | 154 | 7 | 590 | |
| GeneFamily | AAA ATPases | 1.07e-03 | 53 | 154 | 4 | 413 | |
| GeneFamily | Ubiquitin specific peptidases | 1.32e-03 | 56 | 154 | 4 | 366 | |
| GeneFamily | PDZ domain containing | 1.94e-03 | 152 | 154 | 6 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 2.50e-03 | 160 | 154 | 6 | 555 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 PHF20 TRIO ZFYVE16 SEPTIN9 RABGAP1 FAT1 PTPN13 PTPRA BRCA1 CDC16 RABGAP1L SYNE2 PDS5A SCAF8 NPEPPS PPFIA1 AHCTF1 NVL SETD2 C2CD3 ZZZ3 LRIG1 WDFY3 | 2.08e-07 | 856 | 217 | 24 | M4500 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | MDM2 TRIP13 BRCA1 DNAJC9 CDT1 COL6A3 ARCN1 LMO7 CCNB2 KANK3 RCL1 FIGNL1 | 7.39e-07 | 237 | 217 | 12 | M15606 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | MDM2 TRIP13 BRCA1 DNAJC9 CDT1 COL6A3 ARCN1 LMO7 CCNB2 KANK3 RCL1 FIGNL1 | 8.44e-07 | 240 | 217 | 12 | MM976 |
| Coexpression | NABA_CORE_MATRISOME | MATN1 HSPG2 NID2 COL6A3 BCAN VWA7 MMRN1 SNED1 MFAP5 EYS NCAN TNXB | 3.48e-06 | 275 | 217 | 12 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | MATN1 HSPG2 NID2 COL6A3 BCAN VWA7 MMRN1 SNED1 MFAP5 NCAN TNXB | 1.70e-05 | 270 | 217 | 11 | MM17057 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIO SEPTIN9 RABGAP1 FAT1 PTPRA BRCA1 PDS5A SCAF8 NPEPPS PPFIA1 NVL SETD2 C2CD3 ZZZ3 | 3.75e-05 | 466 | 217 | 14 | M13522 |
| Coexpression | GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN | 4.30e-05 | 198 | 217 | 9 | M8355 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP | 4.65e-05 | 200 | 217 | 9 | M4830 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_UP | 5.26e-05 | 116 | 217 | 7 | MM1090 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 6.43e-05 | 10 | 217 | 3 | MM1243 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | TRIP13 NECTIN4 FADS2 CDT1 COL6A3 RIPK4 REST LRIG1 CCNB2 CHTF18 | 6.66e-05 | 260 | 217 | 10 | M1471 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | PTPN13 ATP11A NR3C2 UNC13B DSCAM SLC34A2 CELSR2 LMO7 CGNL1 PATJ | 3.63e-08 | 191 | 217 | 10 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | PTPN13 SYNE2 NR3C2 COBLL1 SLC34A2 SORBS1 LRIG1 LMO7 CGNL1 PATJ | 3.81e-08 | 192 | 217 | 10 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | PLEKHS1 NCKAP5 FAT1 PTPN13 NECTIN4 ERN2 LRIG1 LMO7 RIMS1 PATJ | 4.00e-08 | 193 | 217 | 10 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | SYNE2 NOTCH4 NOVA1 UNC13B COBLL1 SORBS1 ATP10A SLC6A1 SNED1 CGNL1 | 5.60e-08 | 200 | 217 | 10 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | SYNE2 NOTCH4 NOVA1 UNC13B COBLL1 SORBS1 ATP10A SLC6A1 SNED1 CGNL1 | 5.60e-08 | 200 | 217 | 10 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | SYNE2 NOTCH4 NOVA1 UNC13B COBLL1 SORBS1 ATP10A SLC6A1 SNED1 CGNL1 | 5.60e-08 | 200 | 217 | 10 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | SYNE2 NOTCH4 NOVA1 UNC13B COBLL1 SORBS1 ATP10A SLC6A1 SNED1 CGNL1 | 5.60e-08 | 200 | 217 | 10 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | SYNE2 NOTCH4 NOVA1 UNC13B COBLL1 SORBS1 ATP10A SLC6A1 SNED1 CGNL1 | 5.60e-08 | 200 | 217 | 10 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | SYNE2 NOTCH4 NOVA1 UNC13B COBLL1 SORBS1 ATP10A SLC6A1 SNED1 CGNL1 | 5.60e-08 | 200 | 217 | 10 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-07 | 172 | 217 | 9 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-07 | 173 | 217 | 9 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.06e-07 | 175 | 217 | 9 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TANC2 MARCHF10 SEPTIN9 NR3C2 COBLL1 SNED1 CRACDL RIMS1 MRAP2 | 2.87e-07 | 182 | 217 | 9 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-07 | 190 | 217 | 9 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.13e-07 | 190 | 217 | 9 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.31e-07 | 191 | 217 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.51e-07 | 192 | 217 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.51e-07 | 192 | 217 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-07 | 192 | 217 | 9 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.71e-07 | 193 | 217 | 9 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 4.71e-07 | 193 | 217 | 9 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-07 | 194 | 217 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 4.92e-07 | 194 | 217 | 9 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.13e-07 | 195 | 217 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.13e-07 | 195 | 217 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.36e-07 | 196 | 217 | 9 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.59e-07 | 197 | 217 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.83e-07 | 198 | 217 | 9 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-07 | 150 | 217 | 8 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 162 | 217 | 8 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 162 | 217 | 8 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 167 | 217 | 8 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.93e-06 | 170 | 217 | 8 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-06 | 170 | 217 | 8 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 2.11e-06 | 172 | 217 | 8 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.20e-06 | 173 | 217 | 8 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | Healthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class | 2.29e-06 | 174 | 217 | 8 | 97d19ef3240a1f648c6befaabb9ce45ad469cbce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-06 | 179 | 217 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.83e-06 | 179 | 217 | 8 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-06 | 179 | 217 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.95e-06 | 180 | 217 | 8 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-06 | 181 | 217 | 8 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-06 | 181 | 217 | 8 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-06 | 181 | 217 | 8 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.20e-06 | 182 | 217 | 8 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-06 | 183 | 217 | 8 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-06 | 183 | 217 | 8 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 184 | 217 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-06 | 130 | 217 | 7 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 3.62e-06 | 185 | 217 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-06 | 185 | 217 | 8 | a3cd0511fa7cf317c3fcb7082fa785bbf51c5cef | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-06 | 186 | 217 | 8 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.76e-06 | 186 | 217 | 8 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.92e-06 | 187 | 217 | 8 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-06 | 187 | 217 | 8 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 187 | 217 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.92e-06 | 187 | 217 | 8 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasmablasts|bone_marrow / Manually curated celltypes from each tissue | 4.07e-06 | 188 | 217 | 8 | 4caae2acd9ec0eb79b7476a1e59f30f39afddcda | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.07e-06 | 188 | 217 | 8 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-06 | 188 | 217 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.07e-06 | 188 | 217 | 8 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 4.24e-06 | 189 | 217 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.40e-06 | 190 | 217 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 4.40e-06 | 190 | 217 | 8 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 4.40e-06 | 190 | 217 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.40e-06 | 190 | 217 | 8 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.40e-06 | 190 | 217 | 8 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.40e-06 | 190 | 217 | 8 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.40e-06 | 190 | 217 | 8 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.58e-06 | 191 | 217 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.58e-06 | 191 | 217 | 8 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.58e-06 | 191 | 217 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.76e-06 | 192 | 217 | 8 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.76e-06 | 192 | 217 | 8 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.94e-06 | 193 | 217 | 8 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 193 | 217 | 8 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 193 | 217 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-06 | 193 | 217 | 8 | 22ebc3f586eb0aabc5785e468c88d7416c624ff4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 193 | 217 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 4.94e-06 | 193 | 217 | 8 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.94e-06 | 193 | 217 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 4.94e-06 | 193 | 217 | 8 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-06 | 194 | 217 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 5.13e-06 | 194 | 217 | 8 | d70b9039fd2fef3e4be086513b94fb7e9bc1f670 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 5.13e-06 | 194 | 217 | 8 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 5.13e-06 | 194 | 217 | 8 | 5151546812678ae85cb22224084d27b29e3c4724 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.33e-06 | 195 | 217 | 8 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.33e-06 | 195 | 217 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.49e-06 | 139 | 217 | 7 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.53e-06 | 196 | 217 | 8 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 196 | 217 | 8 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.75e-06 | 197 | 217 | 8 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.75e-06 | 197 | 217 | 8 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 197 | 217 | 8 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 5.75e-06 | 197 | 217 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.75e-06 | 197 | 217 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.75e-06 | 197 | 217 | 8 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | TRIO RABGAP1 MDM2 PML WHRN MAN1C1 COBLL1 TEX15 SNED1 MFAP5 PALM PATJ | 3.08e-07 | 192 | 215 | 12 | 4108_UP |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | ZBTB6 PHF20 SEPTIN9 RABGAP1L ATP11A PML USP36 HSPG2 ERN2 EPN2 PHACTR4 CDH6 | 4.52e-07 | 199 | 215 | 12 | 2744_DN |
| Drug | Piromidic acid [19562-30-2]; Up 200; 13.8uM; PC3; HT_HG-U133A | RIN3 PHF20 PLEKHS1 MDM2 RABGAP1L OSBP2 PML COBLL1 GTF2F1 CNTNAP2 PALM | 2.51e-06 | 194 | 215 | 11 | 4575_UP |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | TRIO RABGAP1L HPS1 ZBTB40 KAT5 DSCAM COBLL1 GRB10 CREM MADD USP21 | 3.37e-06 | 200 | 215 | 11 | 7015_DN |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.39e-05 | 190 | 215 | 10 | 7209_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.74e-05 | 195 | 215 | 10 | 4180_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 215 | 10 | 6930_DN | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; PC3; HT_HG-U133A | RIN3 ZBTB40 PDS5A PML COBLL1 APBB1 SLC34A2 CNTNAP2 RIMS1 PATJ | 1.90e-05 | 197 | 215 | 10 | 4627_UP |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; PC3; HT_HG-U133A | TRPC4 RABGAP1 ADD2 EXD3 PTPRB ZBTB40 FAM149B1 COBLL1 PAPOLG RIMS1 | 1.90e-05 | 197 | 215 | 10 | 4017_UP |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.98e-05 | 198 | 215 | 10 | 6362_UP | |
| Drug | prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 215 | 10 | 6590_UP | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | TANC2 RABGAP1L PPFIA4 SORBS1 SETD2 TNFRSF8 CNTNAP2 KIRREL1 PATJ CDH6 | 1.98e-05 | 198 | 215 | 10 | 4669_DN |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 215 | 10 | 4729_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | PLEKHS1 MDM2 FBXO38 RABGAP1L HPS1 ATP11A DSCAM REST ERN2 CDH6 | 1.98e-05 | 198 | 215 | 10 | 5433_DN |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.07e-05 | 199 | 215 | 10 | 3730_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 7.51e-05 | 187 | 215 | 9 | 7368_UP | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 9.56e-05 | 193 | 215 | 9 | 5839_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.56e-05 | 193 | 215 | 9 | 5239_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 9.56e-05 | 193 | 215 | 9 | 2055_UP | |
| Drug | Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.94e-05 | 194 | 215 | 9 | 7479_DN | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 9.94e-05 | 194 | 215 | 9 | 4599_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; PC3; HT_HG-U133A | 9.94e-05 | 194 | 215 | 9 | 4083_UP | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 4577_UP | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 2884_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 6561_UP | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 6285_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 215 | 9 | 4961_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 4472_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 4423_DN | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 196 | 215 | 9 | 2239_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 4485_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 3355_DN | |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 5993_DN | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 3988_UP | |
| Drug | Debrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 3207_DN | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 1.12e-04 | 197 | 215 | 9 | 4767_DN | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 3721_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 4773_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; PC3; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 5096_UP | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 2246_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; PC3; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 4259_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 6738_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 6726_DN | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 4697_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 7521_DN | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 6033_UP | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 2989_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 3553_DN | |
| Drug | Suprofen [40828-46-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 215 | 9 | 3343_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 4348_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; PC3; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 4262_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 4346_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; HL60; HT_HG-U133A | 1.21e-04 | 199 | 215 | 9 | 2545_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.21e-04 | 199 | 215 | 9 | 988_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 200 | 215 | 9 | 3176_UP | |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; PC3; HT_HG-U133A | 1.25e-04 | 200 | 215 | 9 | 3997_DN | |
| Drug | 2,4,4'-trichlorobiphenyl | MAP6 MAS1 URB2 MDM2 TRIP13 BRWD3 RPS6KC1 SYNE2 NECTIN4 NR3C2 CDT1 NOVA1 COL6A3 PPFIA4 CNTRL RIPK4 RFWD3 CDH22 CELSR2 CCNB2 TNFRSF8 RP1L1 CNTNAP2 ST8SIA2 KIRREL1 RIMS1 MRAP2 FIGNL1 | 1.62e-04 | 1411 | 215 | 28 | ctd:C081766 |
| Disease | schizophrenia (is_implicated_in) | 1.19e-06 | 78 | 204 | 7 | DOID:5419 (is_implicated_in) | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 3.22e-06 | 5 | 204 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Schizophrenia | MAP6 DTNBP1 PTPRA BRCA1 NRXN1 FADS2 HSPA1A HSPA1B CNR1 NOTCH4 PML GRB10 GRIA4 REST SLC6A1 NCAN CNTNAP2 ST8SIA2 CGNL1 TNXB | 3.70e-06 | 883 | 204 | 20 | C0036341 |
| Disease | Neurodevelopmental Disorders | 3.90e-06 | 93 | 204 | 7 | C1535926 | |
| Disease | schizophrenia (implicated_via_orthology) | 7.77e-06 | 68 | 204 | 6 | DOID:5419 (implicated_via_orthology) | |
| Disease | complement C4b measurement | 2.50e-05 | 25 | 204 | 4 | EFO_0008092 | |
| Disease | urate measurement, bone density | DTNBP1 EHMT2 RABGAP1L NR3C2 SCFD1 NOTCH4 DSCAM MAN1C1 AHCTF1 RIPK4 DENND1A THAP4 EYS ST8SIA2 TNXB | 2.95e-05 | 619 | 204 | 15 | EFO_0003923, EFO_0004531 |
| Disease | cutaneous melanoma, hair color | 7.07e-05 | 62 | 204 | 5 | EFO_0000389, EFO_0003924 | |
| Disease | hemoglobin A1 measurement | RREB1 PTPRA SYNE2 FADS2 ATP11A CDT1 COBLL1 MADD SETD2 ABCB10 LRIG1 RP1L1 RCL1 | 7.40e-05 | 520 | 204 | 13 | EFO_0007629 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.45e-05 | 152 | 204 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | reticulocyte count | SEPTIN9 RREB1 ARFIP1 FAT1 PTPRA SYNE2 ZBTB40 ATP11A CDT1 SPOCD1 NOTCH4 KAT5 ZCCHC8 COBLL1 REST ZNF792 KANK3 RCL1 PRDX1 | 1.28e-04 | 1045 | 204 | 19 | EFO_0007986 |
| Disease | PITT-HOPKINS SYNDROME | 1.42e-04 | 3 | 204 | 2 | C1970431 | |
| Disease | sphingomyelin measurement | 1.47e-04 | 278 | 204 | 9 | EFO_0010118 | |
| Disease | phosphatidylcholine 38:6 measurement | 1.71e-04 | 16 | 204 | 3 | EFO_0010388 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.76e-04 | 224 | 204 | 8 | EFO_0004530, EFO_0008317 | |
| Disease | Malignant neoplasm of breast | MAGEA4 ABCA4 TRPC4 OBSCN MDM2 BRCA1 SYNE2 HERC2 SPOCD1 HSPA1B NOTCH4 NID2 MICAL1 SORBS1 PANX2 APOL1 MFAP5 SETD2 ABCB10 | 1.81e-04 | 1074 | 204 | 19 | C0006142 |
| Disease | phospholipids:total lipids ratio | 1.93e-04 | 227 | 204 | 8 | EFO_0020946 | |
| Disease | chronic kidney disease | 2.44e-04 | 235 | 204 | 8 | EFO_0003884 | |
| Disease | ceramide measurement | 2.44e-04 | 235 | 204 | 8 | EFO_0010222 | |
| Disease | fatty acid measurement | ABCA4 MAS1 FADS2 USP1 NOTCH4 KAT5 COBLL1 EEF1G CELSR2 KANK3 NCAN | 2.45e-04 | 436 | 204 | 11 | EFO_0005110 |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.62e-04 | 127 | 204 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) measurement | 2.83e-04 | 4 | 204 | 2 | EFO_0022116 | |
| Disease | Intellectual Disability | TANC2 TRIO BRWD3 BRCA1 NRXN1 ZBTB40 DYNC1I2 ZCCHC8 SETD2 P4HTM ZNF335 | 3.03e-04 | 447 | 204 | 11 | C3714756 |
| Disease | feeling nervous measurement | 3.51e-04 | 87 | 204 | 5 | EFO_0009597 | |
| Disease | serum alanine aminotransferase measurement | SEPTIN9 PKD1L1 FADS2 SDC1 NOTCH4 WHRN ARHGEF19 ZCCHC8 COBLL1 AKNA USP21 CELSR2 NCAN RP1L1 PATJ CDH6 | 3.83e-04 | 869 | 204 | 16 | EFO_0004735 |
| Disease | age-related macular degeneration | 3.90e-04 | 89 | 204 | 5 | EFO_0001365 | |
| Disease | body mass index, fasting blood glucose measurement | 4.30e-04 | 51 | 204 | 4 | EFO_0004340, EFO_0004465 | |
| Disease | obsolete_red blood cell distribution width | SP3 ARFIP1 PTPRA NFE2L1 RABGAP1L SYNE2 ZBTB40 FADS2 PDS5A ATP11A OSBP2 CDT1 HSPA8 USP36 KAT5 ZCCHC8 NVL REST LRIG1 RP1L1 RCL1 | 4.53e-04 | 1347 | 204 | 21 | EFO_0005192 |
| Disease | sleep efficiency | 4.69e-04 | 5 | 204 | 2 | EFO_0803364 | |
| Disease | Bipolar Disorder | DTNBP1 NRXN1 FADS2 CNR1 NOTCH4 WHRN DSCAM NCAN CNTNAP2 ST8SIA2 RIMS1 | 5.22e-04 | 477 | 204 | 11 | C0005586 |
| Disease | cholesterol to total lipids in large HDL percentage | 5.74e-04 | 55 | 204 | 4 | EFO_0022234 | |
| Disease | Carcinoma, Pancreatic Ductal | 5.92e-04 | 24 | 204 | 3 | C0887833 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 7.01e-04 | 6 | 204 | 2 | EFO_0800611 | |
| Disease | Orofaciodigital Syndromes | 7.01e-04 | 6 | 204 | 2 | C0029294 | |
| Disease | triglycerides to total lipids in small LDL percentage | 7.50e-04 | 59 | 204 | 4 | EFO_0022337 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 7.50e-04 | 59 | 204 | 4 | EFO_0022248 | |
| Disease | mean platelet volume | RIN3 ATP8B4 PHF20 ARFIP1 NFE2L1 SYNE2 FADS2 NR3C2 MICAL1 PCDHGA6 MAN1C1 NPEPPS SORBS1 REST VWA7 SETD2 PCDHGC3 | 7.74e-04 | 1020 | 204 | 17 | EFO_0004584 |
| Disease | free cholesterol to total lipids in medium HDL percentage | 7.99e-04 | 60 | 204 | 4 | EFO_0022282 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 9.61e-04 | 63 | 204 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 9.61e-04 | 63 | 204 | 4 | EFO_0022239 | |
| Disease | hypersomnia | 9.76e-04 | 7 | 204 | 2 | EFO_0005246 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.02e-03 | 64 | 204 | 4 | EFO_0022253 | |
| Disease | Bilateral Wilms Tumor | 1.04e-03 | 29 | 204 | 3 | C2930471 | |
| Disease | triacylglycerol 56:7 measurement | 1.04e-03 | 29 | 204 | 3 | EFO_0010434 | |
| Disease | triglycerides in small LDL measurement | 1.08e-03 | 65 | 204 | 4 | EFO_0022323 | |
| Disease | colorectal cancer | RIN3 ATP8B4 PLEKHS1 RREB1 ZBTB40 FADS2 OSBP2 HERC2 NOTCH4 NID2 LRIG1 GOLGA8B | 1.08e-03 | 604 | 204 | 12 | MONDO_0005575 |
| Disease | reticulocyte measurement | SEPTIN9 RREB1 ARFIP1 FAT1 PTPRA SYNE2 ZBTB40 ATP11A CDT1 SPOCD1 KAT5 ZCCHC8 COBLL1 REST ZNF792 KANK3 RCL1 | 1.09e-03 | 1053 | 204 | 17 | EFO_0010700 |
| Disease | total lipids in very large HDL measurement | 1.14e-03 | 66 | 204 | 4 | EFO_0022312 | |
| Disease | severe acute respiratory syndrome, COVID-19 | RIN3 SEPTIN9 NRXN1 ATP11A COL6A3 GRB10 EYS PALM GOLGA8B PATJ | 1.17e-03 | 447 | 204 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | squamous cell carcinoma | 1.21e-03 | 67 | 204 | 4 | EFO_0000707 | |
| Disease | forced expiratory volume | RIN3 ATP8B4 ZNF337 SEPTIN9 PLEKHM1 SUOX ZBTB40 BOP1 MICAL1 DSCAM REST SLC6A1 EYS TNXB | 1.26e-03 | 789 | 204 | 14 | EFO_0004314 |
| Disease | triglycerides in very small VLDL measurement | 1.28e-03 | 68 | 204 | 4 | EFO_0022144 | |
| Disease | sarcoma (is_implicated_in) | 1.30e-03 | 8 | 204 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | cholesterol in very large HDL measurement | 1.35e-03 | 69 | 204 | 4 | EFO_0022229 | |
| Disease | glucose measurement | 1.39e-03 | 380 | 204 | 9 | EFO_0004468 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.40e-03 | 118 | 204 | 5 | EFO_0010119 | |
| Disease | mean reticulocyte volume | SP3 URB2 FBXO38 PTPRA ZBTB40 FADS2 OSBP2 USP1 NPEPPS GRB10 REST CHTF18 RCL1 CDH6 | 1.41e-03 | 799 | 204 | 14 | EFO_0010701 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.50e-03 | 71 | 204 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.56e-03 | 121 | 204 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | colorectal cancer (is_implicated_in) | 1.56e-03 | 121 | 204 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.56e-03 | 121 | 204 | 5 | EFO_0004612, EFO_0005271 | |
| Disease | Major Depressive Disorder | 1.57e-03 | 243 | 204 | 7 | C1269683 | |
| Disease | aspartate aminotransferase measurement | BDP1 ABCA4 OBSCN FSTL4 RABGAP1 PLEKHM1 BRCA1 NFE2L1 NOTCH4 WHRN ARHGEF19 COBLL1 AKNA MADD CNTNAP2 | 1.64e-03 | 904 | 204 | 15 | EFO_0004736 |
| Disease | Osteitis Deformans | 1.66e-03 | 9 | 204 | 2 | C0029401 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 1.66e-03 | 9 | 204 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 1.66e-03 | 9 | 204 | 2 | EFO_0800439 | |
| Disease | Major depression, single episode | 1.66e-03 | 9 | 204 | 2 | C0024517 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 1.81e-03 | 35 | 204 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | serum gamma-glutamyl transferase measurement | SP3 SEPTIN9 RREB1 ARHGEF19 COBLL1 PERM1 VMO1 USP21 SETD2 EYS ZZZ3 CELSR2 RP1L1 CGNL1 CDH6 | 1.82e-03 | 914 | 204 | 15 | EFO_0004532 |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.84e-03 | 75 | 204 | 4 | EFO_0022287 | |
| Disease | Nephroblastoma | 1.97e-03 | 36 | 204 | 3 | C0027708 | |
| Disease | triacylglycerol 56:8 measurement | 1.97e-03 | 36 | 204 | 3 | EFO_0010435 | |
| Disease | Hermanski-Pudlak Syndrome | 2.06e-03 | 10 | 204 | 2 | C0079504 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0022035 | |
| Disease | Hermansky-Pudlak syndrome | 2.06e-03 | 10 | 204 | 2 | cv:C0079504 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement | 2.06e-03 | 10 | 204 | 2 | EFO_0800499 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.06e-03 | 10 | 204 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | PR interval | EFCAB5 OBSCN NCKAP5 FAT1 SYNE2 ZBTB40 FADS2 CNR1 HSPG2 PPFIA1 | 2.47e-03 | 495 | 204 | 10 | EFO_0004462 |
| Disease | pain | 2.50e-03 | 196 | 204 | 6 | EFO_0003843 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.51e-03 | 264 | 204 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | Semantic-Pragmatic Disorder | 2.51e-03 | 11 | 204 | 2 | C0454655 | |
| Disease | coagulation factor XA measurement | 2.51e-03 | 11 | 204 | 2 | EFO_0020266 | |
| Disease | psychosocial stress measurement | 2.51e-03 | 11 | 204 | 2 | EFO_0006783 | |
| Disease | Auditory Processing Disorder, Central | 2.51e-03 | 11 | 204 | 2 | C0751257 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 2.51e-03 | 11 | 204 | 2 | OBA_2045176 | |
| Disease | Language Delay | 2.51e-03 | 11 | 204 | 2 | C0023012 | |
| Disease | Language Development Disorders | 2.51e-03 | 11 | 204 | 2 | C0023014 | |
| Disease | Speech Delay | 2.51e-03 | 11 | 204 | 2 | C0241210 | |
| Disease | hip circumference | 2.55e-03 | 338 | 204 | 8 | EFO_0005093 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.76e-03 | 200 | 204 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | amino acid measurement | TANC2 ZFYVE16 PTPRB RABGAP1L ZBTB40 NR3C2 FAT4 COBLL1 GRB10 MMRN1 LRIG1 RP1L1 | 2.82e-03 | 678 | 204 | 12 | EFO_0005134 |
| Disease | lung adenocarcinoma (is_marker_for) | 2.90e-03 | 85 | 204 | 4 | DOID:3910 (is_marker_for) | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 3.00e-03 | 12 | 204 | 2 | EFO_0800500 | |
| Disease | sialate O-acetylesterase measurement | 3.00e-03 | 12 | 204 | 2 | EFO_0803073 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.03e-03 | 86 | 204 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 3.07e-03 | 42 | 204 | 3 | EFO_0022255 | |
| Disease | psoriatic arthritis | 3.16e-03 | 87 | 204 | 4 | EFO_0003778 | |
| Disease | chronic obstructive pulmonary disease | EFCAB5 RIN3 ATP8B4 RREB1 FBXO38 EHMT2 BTN1A1 NOVA1 COL6A3 VWA7 PRDX1 PPP1R18 | 3.17e-03 | 688 | 204 | 12 | EFO_0000341 |
| Disease | triglycerides in large LDL measurement | 3.28e-03 | 43 | 204 | 3 | EFO_0022319 | |
| Disease | free cholesterol to total lipids in IDL percentage | 3.28e-03 | 43 | 204 | 3 | EFO_0022278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REASQEQPVSLTVVG | 1306 | Q14146 | |
| SSDEEDIRNTVGNVP | 126 | Q14137 | |
| AEASARVENSPQVDG | 856 | Q8WVB6 | |
| TERENPEAETVSVLG | 671 | A6H8Y1 | |
| VNRGISQAPVTATED | 396 | Q86TW2 | |
| SLESLEGQPVTTQDR | 246 | Q7Z7A1 | |
| EGQPVTTQDRQEAFE | 251 | Q7Z7A1 | |
| EQGITRSQVQAEAPV | 616 | P78363 | |
| ADGPERVTVIANAQD | 476 | Q13410 | |
| QIPGTQTESRAEELS | 431 | Q12774 | |
| NPQTGQITVTAELDR | 3456 | Q6V0I7 | |
| DLVIDSRPTAGQASE | 586 | C9J069 | |
| AEIPVTSNGEVDDSR | 11 | P53367 | |
| QIPGTQTESRAEELS | 431 | A5YM69 | |
| EQEADGAAPQLTASR | 276 | Q9H211 | |
| GADDPSSVTAEEIQR | 591 | Q9NRK6 | |
| REVQSESAQEPGGVS | 206 | Q96CA5 | |
| EGESSESVVPERQQD | 1341 | Q6RI45 | |
| SEAQEVTIPRGDGVT | 541 | Q96KQ7 | |
| TEEELAPGRSSVAVN | 381 | O00213 | |
| VQSPDEGALVTAARN | 491 | Q8TF62 | |
| ARVTATDPDEGTNAQ | 941 | Q9HCU4 | |
| SDENSRVTALQPVDG | 376 | Q53SF7 | |
| REDTVGSTQPQVLAS | 861 | Q5H9R4 | |
| SEEEEVVPRGGSVSQ | 466 | O60312 | |
| DDLQTNVEIIPGESA | 6 | Q5TC04 | |
| REPGTATSQEDVVPQ | 51 | Q8N123 | |
| VTGQRPETAAAEEAS | 6 | Q9NXG6 | |
| QDVTGPDNGVRESET | 131 | Q14494 | |
| VLRGVTNDQVDPSVD | 116 | Q9Y2P8 | |
| REITGVQAQPGEATS | 271 | O75781 | |
| EEQRSQSVRPGADVT | 1776 | P98160 | |
| PVRIESSSSTVAEGQ | 2246 | P98160 | |
| IEPSSSRVAEGQTLD | 2831 | P98160 | |
| ETGVSENEENPVRII | 1191 | Q29RF7 | |
| LGEDTVENINPRTSE | 86 | Q6PCD5 | |
| VQEERLGTEPTSETQ | 511 | O15381 | |
| DSPVGSQVAIVSARD | 256 | Q9Y5E7 | |
| EPGQVVQEQALSTEE | 161 | Q8IW93 | |
| QRSEVTQAPGEYTVD | 1071 | Q6IE37 | |
| QLPQEATESESRGAI | 391 | Q96GW7 | |
| VLVSRQGDETPSTNN | 26 | Q9Y3P9 | |
| NQGEGAAEREVSVPT | 6 | O95864 | |
| SVVQVRATDSDSEPN | 2301 | Q14517 | |
| RENLTGINSTVEEPV | 956 | Q13127 | |
| VVGATNRPQEIDEAA | 541 | Q6PIW4 | |
| EAQTEGRTVPAAVTD | 1076 | P23467 | |
| NDNVPEVVVTSGSRT | 341 | Q9Y5G7 | |
| DITGNLDSPRVTVAQ | 211 | P0C5J1 | |
| QVSQAVERSSLGPTE | 21 | P08235 | |
| VVTDGRPQDSVQDVS | 151 | P21941 | |
| SQRTDQDSVIGVSPA | 1171 | Q8WXG6 | |
| VGAQAPTTEEQEAAV | 26 | P43358 | |
| ETRGLNVPQVTEAEE | 21 | O15479 | |
| VEEPTNISTGRNASV | 11 | P04201 | |
| SARAVAIETQPAQGE | 61 | Q96JE9 | |
| SATPVVSRGAQEDIE | 1456 | Q5T1H1 | |
| DRQETVVRTEGGPQA | 851 | Q96JA1 | |
| EDAGAPVRVTANSVS | 151 | Q6ZVW7 | |
| PEDGAADVRVIISNS | 491 | O43824 | |
| AQDTISRGSDDSVPV | 656 | Q96S38 | |
| ERQTGAAADIPQTAV | 201 | Q86YD7 | |
| DSQSGRLSSQPVVVE | 3601 | O95714 | |
| SETSAPAEGVRNQTL | 86 | Q13201 | |
| VSSELEQARPQTSGE | 261 | O95208 | |
| RQAQSPSGVSSEVEV | 136 | O75335 | |
| DEVTLQVSGEREGSP | 326 | Q76MJ5 | |
| SESGERPQITINEIS | 431 | Q92993 | |
| NDTEVPTASISVEGN | 556 | Q13409 | |
| ADITGNLDSPRVTVA | 176 | Q8N7N1 | |
| DVPTLGNDTAAIENR | 401 | P48058 | |
| VEIIANDQGNRTTPS | 26 | P0DMV9 | |
| ATRDISEGGESPVVQ | 306 | Q96EV8 | |
| ASEQSETVQPGDEIL | 1271 | Q14005 | |
| GDVEDIKRTPNNVVS | 941 | Q8WWI1 | |
| RQAQSPAGVSSEVEV | 146 | Q13136 | |
| NGRTVEETQVPEISG | 246 | Q8TDZ2 | |
| EEALGTRTEGPSVVQ | 26 | E5RJM6 | |
| DVRVNSSQVLPVDSG | 186 | Q9ULB1 | |
| DAPSGTRVVQVLATD | 256 | Q9UN70 | |
| ERGPLSEQVSEAVSE | 61 | Q969R2 | |
| IGNARSSSPVQVEEE | 111 | Q8IZ21 | |
| QSQTRNEVIAIESGP | 56 | Q6NV74 | |
| VNSQRGDDVTQATPE | 26 | Q13361 | |
| PEGSVRIIDQSSNVE | 176 | Q5R372 | |
| AESLPGATTRQDQVE | 231 | Q96IR7 | |
| QITVNDLPVGRSVDE | 141 | Q06830 | |
| AGTEPSDAIRVVNAV | 266 | Q15645 | |
| TSAQPVEGAVEERER | 296 | Q86UR5 | |
| KEQPASREVQAEAGT | 1536 | Q5VST9 | |
| REVTVTGPLQDAEAT | 2556 | Q5VST9 | |
| TVRITQTAEGLDPEN | 626 | Q14112 | |
| SQAIIPVDVDEEQAG | 566 | Q6PIJ6 | |
| GETERNSAEPAAVIV | 556 | Q9BWT3 | |
| QITPQGTRDEISLDS | 206 | P38398 | |
| EVRAPNSDSAEEGQV | 341 | B2RXH4 | |
| GVTAEQGPQRISIEE | 511 | A4FU69 | |
| SETVIPESVDGLQEN | 216 | Q13042 | |
| VSQETEPEREAGLQN | 676 | Q711Q0 | |
| RSEGAVVNVQPTDKE | 266 | O75054 | |
| STTAEVRLTQEGPAD | 1616 | Q4AC94 | |
| NSESEEEVGIPASLQ | 456 | Q96SD1 | |
| RPTVSSDLENIDTGV | 6 | O95067 | |
| LETEGSQESTVIRAP | 471 | Q0VF96 | |
| VGESQAEEPRSFEVT | 36 | Q6MZW2 | |
| NQEDFSVVVEPGVTR | 126 | Q86WU2 | |
| ADRSGDDVRNPSVVV | 1141 | P12111 | |
| NVEVSSGNSEVEDRP | 726 | Q7Z591 | |
| VTEPISAESGEQVER | 306 | O14791 | |
| SAESGEQVERVNEPS | 311 | O14791 | |
| TSEDGKVQVTRPDQA | 321 | P21554 | |
| REGNPVTELDNITSS | 701 | Q8NEE6 | |
| QGTVDEDSPVLTQDR | 81 | Q8WXX5 | |
| VLGTRADESQEPQSQ | 156 | Q9NR34 | |
| VREAEDTTLTSQPQG | 541 | Q8NA82 | |
| TNLEVPDTEGAVSSR | 161 | P10911 | |
| GDEAESPEQQVRKST | 541 | Q8TEH3 | |
| TREAGAQAVPETREA | 311 | Q6NY19 | |
| AQAVPETREAGVEAA | 316 | Q6NY19 | |
| EPADQTVVAGQRAVL | 26 | Q96J84 | |
| TGRVIENPAEAQSAA | 441 | Q13322 | |
| TIGSVTAQDPDAARN | 401 | P55285 | |
| NEEEQERPVGVLTSS | 86 | A4QMS7 | |
| GDEASAVRTNSPLQV | 476 | Q9UHC6 | |
| PVSQVVVGDTDRQGS | 766 | Q9UHC6 | |
| SLVGVVTARDPDAAN | 411 | Q9UJ99 | |
| NEELRGSTPEAAAQV | 81 | P26641 | |
| REEGVNEALSPDTSV | 366 | Q8WYP5 | |
| TTTAQGRSPVEVAQD | 261 | Q6IAN0 | |
| VEIIANDQGNRTTPS | 26 | P0DMV8 | |
| ASLTNSVEPAQGEAR | 541 | A8MQT2 | |
| TTQNPNGTESEISVR | 71 | Q9NQ60 | |
| VIQAVNTSPERGGEE | 191 | Q92902 | |
| GSQVVVQDEETELAP | 226 | Q03060 | |
| NSSAGVEAAEQRPVE | 306 | Q6NYC8 | |
| GENTRSVIPNDISSN | 781 | Q9UPN6 | |
| STAQEADPEVRSNAI | 906 | Q8TEX9 | |
| EEDVATQQPVSRSQG | 76 | Q5SV97 | |
| NTGEARTEESPLVDI | 2821 | Q8TDX9 | |
| SEEVRPQDTVSVIGG | 801 | P55786 | |
| VTQVDGNSPVRFSTE | 486 | P48444 | |
| SQQEVISALRGTAPE | 1566 | Q12923 | |
| RLSNGRTEDVEPQSV | 191 | P18433 | |
| TVRDSGVQTVDPSAN | 396 | Q96RD6 | |
| PRESTEQGQDTEVKA | 426 | Q8TB24 | |
| VEIIANDQGNRTTPS | 26 | P11142 | |
| VTVSGEPEQNRKAVE | 221 | P51513 | |
| VVETRGSALDDAVNP | 856 | Q9BVI0 | |
| GDSSRAQSAVVDEPN | 496 | Q96BN6 | |
| EETTNDNGVLVLEPA | 296 | P43121 | |
| VSQATGPLVDVSDAR | 1711 | O60469 | |
| QQPSSTVSETAREVG | 396 | Q9Y4G2 | |
| TPNSGDVQVTEDAVR | 446 | P35269 | |
| EDSVPQSNGELTVRA | 441 | Q4VX76 | |
| TSQQEPQILVDRGSE | 26 | Q5H9L4 | |
| PSTNVRSADQENGEI | 846 | A5PLK6 | |
| GQISTEVSEAPVAND | 11 | P30531 | |
| EEQDRTNLQVPSGVS | 331 | Q17RD7 | |
| RSIQNVPESSGAVET | 3536 | Q8WXH0 | |
| ITAGERNVTLPDSQA | 1201 | O14513 | |
| AQTLEREVPSSTDGQ | 1766 | O14513 | |
| GQRVTSTPQADSERE | 1056 | Q5HYW2 | |
| QEEPQSLQAAVRTDG | 361 | P29590 | |
| RETGETSPAQVNKAE | 706 | O14594 | |
| DGAVTTSQIPASEQE | 11 | Q00987 | |
| VAEATPRSQEATEAA | 231 | Q9UHD8 | |
| EVVINGSSSPAVVDR | 56 | Q92186 | |
| SQDEVSRGVEPLEAA | 11 | Q86UG4 | |
| SGENTAVVAVEPDRR | 216 | P18827 | |
| ENVSIGLQTEARPSQ | 1421 | Q9HCD6 | |
| RVEAPTTLGDNTAAN | 126 | Q7Z5L0 | |
| LPDVSVDDVRSTSQG | 561 | Q9P202 | |
| QTAVDARTEDGTTPL | 1691 | Q99466 | |
| VSQAVEGPEELSRSS | 391 | P57078 | |
| EDTDQTRVVPGAAEN | 76 | Q5JPH6 | |
| RPVEGFEVTNVTAST | 1006 | Q8TER0 | |
| TTQPEGVVVNGREEE | 641 | P35612 | |
| SSSPDEVALVEGVQR | 506 | P98196 | |
| DNITISREAQGEVPA | 666 | O95436 | |
| PDGTAVSTEDALRQV | 351 | Q70EK8 | |
| SIETDGPDQVSGRIE | 231 | Q5SXH7 | |
| PQTRTASGAVDEDAL | 501 | Q6NZY4 | |
| RVSPVSENQVASSEG | 536 | Q9UK80 | |
| ASSEGTVPQVQREEP | 476 | Q5TAP6 | |
| EFPRNVTATEGQNVE | 31 | Q8TAG5 | |
| QDISAERSPNGVQLE | 91 | Q147U1 | |
| SESVSGQRPNTSVEQ | 2666 | Q8IZQ1 | |
| NRQVTLEVSGAEPQS | 126 | Q8WVN6 | |
| DVQLQEAIRSSGQPE | 141 | Q96G30 | |
| QGTEQATGAAVTREP | 596 | Q8IWN7 | |
| DQTSRSGVPAQVQSE | 201 | Q969K3 | |
| DREQPSEGATELRQV | 1291 | Q92766 | |
| ELRQVAGDAPVEQAT | 1301 | Q92766 | |
| LQVQQDGSETTRVPT | 451 | Q8WTU2 | |
| NEPSESQEARTGRTV | 916 | Q8NI35 | |
| RTGERVSPDINETNT | 311 | Q02447 | |
| VVRTGSDEGQAPAQD | 346 | Q6ZMY3 | |
| VSERRVGEQDSAPTQ | 331 | Q9BX66 | |
| AADQRTVTVEDLEPG | 3496 | P22105 | |
| QLRSGASVTEPVAEE | 446 | P28908 | |
| RVNLEESSGVENSPA | 291 | Q8WVM8 | |
| VRSQTTQGSGVDDPV | 1406 | O14795 | |
| TVRVSVDGVPVTENN | 111 | Q86WI1 | |
| GVSDVESERSQEQPD | 1986 | Q9BYW2 | |
| PRINEEAGDTERTQS | 2156 | Q8IUG5 | |
| ESREVNPGDVSLNNI | 1126 | Q86YA3 | |
| VSVEGVAQDRSPEAT | 111 | Q3KQV3 | |
| ASTEQNEVPRVVTSG | 21 | Q8TF39 | |
| NEVPRVVTSGEQEAI | 26 | Q8TF39 | |
| QSAITEPRDGETVES | 426 | P51687 | |
| ISQEGDEPAREQSVS | 231 | Q5QJ38 | |
| VPAVRGEDVQLTEDQ | 611 | Q5QJ38 | |
| NIRQESGPVSNSEIS | 841 | Q9BXT5 | |
| KTATITEPRGNEEAQ | 561 | Q15029 | |
| VSRTPVEAGVSQSDA | 406 | Q9H4Z2 | |
| TAEDTPGVRVQAQTS | 586 | Q9Y334 | |
| QETVERLGQSPAQDT | 61 | P0C6A0 | |
| NVSEEGPLNSAVVEE | 181 | Q8IYH5 | |
| GEATPRAAQEAASQE | 151 | Q8WY91 | |
| SVSEEVARQQAAGPL | 866 | Q9UBN4 | |
| RPEDTAASALQEGQT | 851 | Q9P275 | |
| DEEVSIRVGGNTQPS | 641 | O94782 | |
| SAATPQDETVEERGR | 1821 | O75962 | |
| NETGDITRNEIIQSP | 926 | Q7Z3T8 | |
| VQGQVVRDVSAPSSE | 121 | Q9NUA8 | |
| EIESSQGQRENPTEI | 151 | Q9Y3M9 | |
| INSTVESRVAEVPGN | 256 | Q15916 | |
| VSLTDSVEPVQGETR | 541 | A6NN73 | |
| PRSSGDEATQSQAVQ | 756 | Q8N9H8 | |
| IDVEAPRQDASGQSL | 151 | Q14324 | |
| SQVTVDVLDPQEDSG | 326 | Q96NY8 |